Metallothionein expression in transplantable mouse mammary tumors

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 379-384

  Yamamura, Yuichi ^a   Sayama, Kazutoshi ^b   Takeda, Yasutaka ^c   Matsuzawa, Akio ^c   Iguchi, Taisen ^d   Ohta, Yasuhiko ^e  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b SHIZUOKA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e TOTTORI UNIVERSITY   (Japan)

Author keywords

Metallothionein; Mouse; Transplantable mammary tumor

Indexed keywords

METALLOTHIONEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER CELL; CANCER GRAFT; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; CHROMATOGRAPHY; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL METAPLASIA;

ADENOCARCINOMA; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CYTOPLASM; ESTROGENS; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; METALLOTHIONEIN; METAPLASIA; MICE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0034109563     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hamer DE: Metallothionein. Annu Rev Biochem 55: 913-951, 1986.
2. Kagi JH: Overview of metallothionein. Methods in Enzymol 205: 613-626, 1991.
3. Kontozoglou TE, Banerjee D and Cherian G: Immunohistochemical localization of metallothioncin in human testicular embryonal carcinoma cells. Virchows Archiv A 415: 545-549, 1987.
4. Cherian MG, Huang PC, Klaasscn CD, Liu Y-P, Longfellow DG and Waalkes MP: National cancer institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res 53: 922-925, 1993.
5. Schmid KW, Ellis IO, Gee JNW, Darke BM, Lees WE, Kay J, Cryer J, Stark JM, Hittmair A, Ofner D, Dunser M, Margreiter R, Daxenbichler G, Nicholson RI, Bier B, Bocker W and Jasani B: Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of breast. 20 Virchow Arch A 422: 153-159, 1993.
6. Fresno M, Wu W and Rodrigues JM: Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchow Arch A 43: 215-219, 1993.
7. Cherian MG, Howell SB, Imura N, Klaassen CD, Koropatnick J, Lazo JS and Waalkes MP: Role of metallothionein in carcinogenesis, Toxicol Appl Pharmacol 126: 1-5, 1994.
8. Haerslev T, Jacobsen K, Nedergaard L and Zedeler K: Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastasis. Pathol Res Pract 190: 675-681, 1994.
9. Douglas-Jones AG, Frepa KW, Schmid KW, Bier B, Horgan K, Lyons K, Dallimore ND and Moneypenny IJ: Metallothionein expression in duct carcinoma in situ of the breast. Hum Path 26: 217-222, 1995.
10. Goulding H, Jasani B, Percira H, Reid A, Galea M, Bell JA, Elston CW, Robertson JF, Blamey RW, Nicholson RA, Schimd KW and Ellis IO: Metallothionein expression in human breast cancer. Br J Cancer 72: 968-972, 1995.
11. Reid A, Pereira H, Galea M, Bell JA, Elston CW, Jasani B, Schimid KW, Kay J and Cryer A: Metallothionein in human breast cancer. J Pathol Suppl 767: 29A, 1992.
12. Bier B, Dauglas-Jones AG, Totsch M, Dockhorn-Dworniczak B, Boker W, Jasani B and Schmid KW: Immunohistochemical demonstration of metallothionein in normal human breast tissue and malignant breast lesions. Breast Cancer Res Treat 30: 213-221, 1994.
13. Oyama T, Takei H, Hikino Y, Iino Y and Nakajima T: Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis. Oncology 53: 112-117, 1996.
14. Yamamura Y, Sayama K, Takeda Y, Matsuzawa A, Iguchi T and Ohta Y: Differences in metallothionein expression in transplantable mouse mammary tumor lines. Cancer Lett in press.
15. Takeda Y, Matsuzawa A, Kaneko T, Sekiguchi M and Fujii G: Effects of repeated exposure to cyclophosphamide on drug resistance and 14 biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320). Jpn J Exp Med 58: 87-98, 1988.
16. Andrews GK, Murphy MP and Howell SB: Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother Pharmacol 19: 149-154, 1987.
17. Kelley SL, Basu T and Teicher BA: Overexpression of metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815, 1988.
18. Webber MM, Regman SMM and James GT: Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin. Cancer Res 48: 4503-4508, 1988.
19. Matsuzawa A and Yamamoto T: A transplantable pregnancy-dependent mammary tumor line (TPDMT-4) in strain DDD mice. Jpn J Cancer Res 65: 306-315, 1974.
20. Matsuzawa A, Kaneko T, Murakami A and Tanaka H: Enhancement of tumorigenetic potential in virgin mice of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by enzymatic cell dissociation. Carcinogenesis 9: 971-977, 1988.
21. Straus W: Imidazole increases the sensitivity of the cytochemical reaction for peroxidase with diaminobenzidine at a neutral pH. J Histochem Cytochem 30: 491-493, 1982.
22. Shinogi M, Nishinaga K and Yokoyama I: Measurement of metallothionein in rat tissues by a chromatographic method using the fluorometry of thiol groups. Biol Pharm bull 19: 911-914, 1996.
23. Dunn TB: Morphology of mammary tumors in mice. In: Physiophathology of cancer (Homburger F, ed). New York, Hoeber, 1959, pp 38-84.
24. Murakami A, Tanaka H and Matsuzawa A: Association of hst expression with metastatic potential in mouse mammary tumors. Cell Growth Diff 1: 225-231, 1990.
25. Takeda Y, Sayama K, Saegusa Y and Matsuzawa A: Progression toward metastatic phenotype with loss of Growth-inhibiting tumor-cell/cell interactions in vitro. Int J Cancer 62: 579-584, 1995.
26. Matsuzawa A: Hormone dependence and independence of mammary tumors in mice. Int Rev Cytol 103: 303-340, 1986.
27. Matsuzawa A, Hayakawa T, Takitani S and Iwaguchi T: Comparative studies on estrogen receptors between a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous tumors. Endocrinology 120: 2346-2356, 1987.
28. Imai S, Torimoto J, Tsubura Y and Hilgers J: Mammary tumor induction in inbred mouse strains with urethane is not accompanied by changes in expression of B- and C-type retroviral structural proteins. Int J Cancer 30: 101-106, 1982.
29. Nartey N, Cherian MJ and Banerjee D: Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Path 129: 177-182, 1987.
30. Murphy D, McGrown AT, Crowther D, Mander A and Fox BW: Metallothionein levels in ovarian tumors before and after chemotherapy. Br J Cancer 63: 711-714, 1991.
31. Bahnson RP, Banner BF and Ernstoff MS: Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol 146: 1518-1520, 1991.
32. Zelger B, Hittmair A, Schir M, Öfner C, Öfner D, Fritsch P, Bocker W, Jasani B and Schmid KW: Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 23: 257-264, 1993.
33. Chin JL, Banerjee D and Kadhim SA: Metallothionein in testicular germ cell tumors and drug resistance. Cancer 72: 3029-3035, 1993.
34. Udom AO and Brady FO: Reactivation in vitro of zinc-requiring apoenzymes by rat liver zinc-thionein. Biochem J 187: 329-335, 1980.
35. Murphy G, Reynolds JJ and Hembry RM: Metalloproteinases in cancer invasion and metastases. Int J Cancer 44: 757-760, 1989.
36. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenisis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.